[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"King Abdullah Medical City\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":81},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,48],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":31,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":37,"lastUpdatePostDateStruct":38,"startDateStruct":41,"completionDateStruct":43,"leadSponsor":45,"locationsCount":5},"100607845","phase-4-zinc-oxide-vs-mebo-100607845",false,"NCT07193849","Zinc Oxide VS MEBO","Impact of Using Zinc Oxide Versus Moist Exposed Wound Ointment (MEBO) in Treatment of Second Stage Pressure Ulcer: A Randomized Control Clinical Trial","Inclusion Criteria:\n\n* Willing to participate.\n* KAMC cases in medical ward, neuroscience ward, and intensive care unit.\n* Newly cases diagnosed with second stage pressure ulcer according to the European pressure ulcer advisory panel\u002Fnational pressure ulcer advisory panel (NPUAP) guidelines.\n\nExclusion Criteria:\n\n* Not consenting to participate\n* Patients with suspected hypersensitivity reactions to any of the topical formulation's ingredients.\n* Either a category III or IV pressure ulcer.\n* Evidence of deep tissue injury (exudative drainage, purple or maroon localized area of discolored intact skin or blood-filled blister due to pressure damage).\n* Signs of wound infection (pus draining from the ulcer, a foul-smelling odour, tenderness, heat and increased redness in the surrounding skin and fever).\n* Patients who undertaking other therapies that could affect healing, such as corticosteroids, radiation therapy, or chemotherapy for cancer.\n* Heavy smoking (more than 20 cigarettes a day).\n* Concomitant chronic disease (e.g., diabetes mellitus or frank vascular disease such as Buerger's disease).\n* Patients who unable to continue the study because of death, discharge, or change in the care setting.","ALL","18 Years",{"count":19,"type":20},76,"ESTIMATED","INTERVENTIONAL",[23],"PHASE4","randomize control trial to evaluate the efficacy of using zinc oxide versus moist exposed wound ointment in treatment of second stage pressure ulcer.",[26,27,28,29,30],"Pressure Injury","Pressure Injury Stage 2","Bedsore","Pressure Ulcers Stage II","Pressure Ulcer, Buttock",[32,33,34,35],"pressure injury","pressure ulcer","MEBO","Zinc oixid","RECRUITING","2025-09-22",{"date":39,"type":40},"2025-09-26","ACTUAL",{"date":42,"type":40},"2023-12-31",{"date":44,"type":20},"2025-12-31",{"name":46,"class":47},"King Abdullah Medical City","OTHER_GOV",{"id":49,"slug":50,"hasResults":11,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":56,"targetDuration":4,"studyType":21,"phases":58,"briefSummary":60,"conditions":61,"keywords":66,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":80},"100576821","polyurethane-foam-pink-pad-rct-use-in-or-100576821","NCT06790277","Polyurethane Foam-Pink Pad (RCT) Use in OR","Effectiveness of Polyurethane Foam (Pink Pad) Compared With Mepilex Dressing for Pressure Ulcer Prevention in Operating Room: A Randomized Control Clinical Trial","pink-pad","Inclusion Criteria:\n\n* Subjects ≥ 18.\n* Willing to participate.\n* Patients undergoing cardiac surgery.\n* Patient who is at risk for PU development as measured with Braden scale.\n* Patient who has skin intact and having a life expectancy greater than 72 hours as per clinical judgement.\n\nExclusion Criteria:\n\n* Subjects under 17\n* Not consenting to participate\n* Patients with suspected hypersensitivity reactions to any of the dressing formulation's ingredients.\n* Patients who are unable to continue the study because of death or change in the care setting.",{"count":57,"type":20},100,[59],"NA","King Abdullah medical city has a cardiac center, and a lot of open-heart surgeries are performed there, and both polyurethane foam (pink Pad) and Mepilex dressing are applied to those patients. Therefore, the present study was designed to compare the effects of polyurethane foam (pink Pad) versus Mepilex dressing for prevention of pressure ulcer in operating room.",[62,63,64,65],"Cardiac Surgery Subjects","Pressure Ulcer Prevention","Pressure Ulcer of Skin","Pressure Ulcer",[67,68,69,70,71],"five layers sacral foam dressing","PINK PAD","pressure ulcers","Patients undergoing cardiac surgery","Mepilex dressing","2025-01-21",{"date":74,"type":40},"2025-01-24",{"date":76,"type":40},"2023-10-10",{"date":78,"type":20},"2025-10-10",{"name":46,"class":47},1,""]